These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 3018081

  • 1. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L, O'Reilly D, Klempner MS, Rocklin RE.
    J Immunol; 1986 Sep 15; 137(6):1897-903. PubMed ID: 3018081
    [Abstract] [Full Text] [Related]

  • 2. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
    Seligmann BE, Fletcher MP, Gallin JI.
    J Immunol; 1983 Apr 15; 130(4):1902-9. PubMed ID: 6131922
    [Abstract] [Full Text] [Related]

  • 3. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L, Aksamit RR.
    J Immunol; 1984 Sep 15; 133(3):1471-6. PubMed ID: 6086757
    [Abstract] [Full Text] [Related]

  • 4. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP, Seligmann BE, Gallin JI.
    J Immunol; 1982 Feb 15; 128(2):941-8. PubMed ID: 6274963
    [Abstract] [Full Text] [Related]

  • 5. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.
    Weisbart RH, Golde DW, Gasson JC.
    J Immunol; 1986 Dec 01; 137(11):3584-7. PubMed ID: 3491142
    [Abstract] [Full Text] [Related]

  • 6. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
    Marasco WA, Feltner DE, Ward PA.
    J Cell Biochem; 1985 Dec 01; 27(4):359-75. PubMed ID: 2987275
    [Abstract] [Full Text] [Related]

  • 7. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D, Malech HL, Gallin JI.
    J Immunol; 1987 Nov 01; 139(9):3034-40. PubMed ID: 3668252
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L, Yancey KB, Katz SI.
    J Immunol; 1986 Aug 15; 137(4):1305-11. PubMed ID: 3016092
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
    Atkinson YH, Lopez AF, Marasco WA, Lucas CM, Wong GG, Burns GF, Vadas MA.
    Immunology; 1988 Jul 15; 64(3):519-25. PubMed ID: 2842255
    [Abstract] [Full Text] [Related]

  • 10. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H, Gallin JI.
    J Immunol; 1981 Sep 15; 127(3):839-44. PubMed ID: 6790618
    [Abstract] [Full Text] [Related]

  • 11. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P, Barbacane RC, Reale M, Panara MR, Placido FC, Mier JW, Castracane JM, Dempsey RA.
    Biotechnol Ther; 1993 Sep 15; 4(3-4):239-52. PubMed ID: 8292972
    [Abstract] [Full Text] [Related]

  • 12. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H, Bylund J, Karlsson A, Pellmé S, Dahlgren C.
    Immunology; 2004 Jun 15; 112(2):201-10. PubMed ID: 15147563
    [Abstract] [Full Text] [Related]

  • 13. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA, Becker EL.
    J Immunol; 1982 Feb 15; 128(2):963-8. PubMed ID: 7054297
    [Abstract] [Full Text] [Related]

  • 14. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.
    Zimmerli W, Seligmann B, Gallin JI.
    J Clin Invest; 1986 Mar 15; 77(3):925-33. PubMed ID: 3005369
    [Abstract] [Full Text] [Related]

  • 15. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM, Huang CK, Becker EL.
    J Immunol; 1982 Oct 15; 129(4):1608-11. PubMed ID: 6286772
    [Abstract] [Full Text] [Related]

  • 16. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
    Andersson T, Dahlgren C, Pozzan T, Stendahl O, Lew PD.
    Mol Pharmacol; 1986 Nov 15; 30(5):437-43. PubMed ID: 2430168
    [Abstract] [Full Text] [Related]

  • 17. Organelle-depleted human neutrophil cytoplasts used to study fmet-leu-phe receptor modulation and cell function.
    Gallin JI, Metcalf JA, Roos D, Seligmann B, Friedman MM.
    J Immunol; 1984 Jul 15; 133(1):415-21. PubMed ID: 6327824
    [Abstract] [Full Text] [Related]

  • 18. Mobilization and adaptation of human neutrophil chemoattractant fMet-Leu-Phe receptors.
    Gallin JI, Seligmann BE.
    Fed Proc; 1984 Sep 15; 43(12):2732-6. PubMed ID: 6088296
    [Abstract] [Full Text] [Related]

  • 19. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA, Showell HJ, Freer RJ, Becker EL.
    J Immunol; 1982 Feb 15; 128(2):956-62. PubMed ID: 7033385
    [Abstract] [Full Text] [Related]

  • 20. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH, Kay AB.
    Clin Exp Immunol; 1981 Feb 15; 43(2):399-407. PubMed ID: 6268337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.